CompletedNCT05296473
Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
Device studyAges 22–55United States
Understand this study
Who was this study for?
Listed age limits: 22 years to 55 years.
- Listed locations
- Scottsdale and 12 more locationsSee all locations and recruitment
Study information
Study start dateStarted: May 5, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 560
- Sponsor
- Lumos Labs, Inc.
- Sponsor type
- Other organization
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 22 Years to 55 Years
- Official registry ID
- NCT05296473
- Official title
Show the full official title
Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Randomized, Controlled, Parallel-group, Intervention Study to Assess an At-home, Game-based Digital Therapy for Treating Adult Patients With Attention-Deficit/Hyperactivity Disorder
Recruitment & locations
CompletedScottsdale · Garden Grove · Sacramento
10 more locations
- San Francisco
- Maitland
- Saint Charles
- Lincoln
- Las Vegas
- Cherry Hill
- Durham
- Raleigh
- Memphis
- Dallas
Questions about this study
Who is behind this study?
The study sponsor is Lumos Labs, Inc.
Who was this study for?
Listed age limits: 22 years to 55 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me